RxSight Forecasts Strong Q4 2024 Revenue Growth

RxSight Inc. expects substantial revenue growth for Q4 2024, with a forecast of about $40.2 million, up 41% year-over-year. This growth suggests a positive trend that could potentially boost investor confidence and stock price.

Date: 12-01-2025

AI Rating: 7

Revenue Growth
RxSight Inc. (RXST) projects revenue for the fourth quarter of 2024 to be about $40.2 million, indicating a growth of approximately 41% compared to the same period last year. Furthermore, the company has a favorable outlook for the full-year 2025, anticipating revenue in the range of $185.0 million to $197.0 million. This reflects a growth rate of 32% to 41% over 2024, highlighting a strong demand for its products and services.

Gross Profit Margin
The company estimates its gross profit margin for the full year 2025 to be between 71% to 73%. This indicates that the company is effectively managing its production costs relative to its revenues, which should reassure investors of its profitability potential.

Operating Expenses
In addition, RxSight expects its operating expenses for 2025 to range between $165.0 million and $170.0 million. Of these expenses, non-cash stock-based compensation is projected to be between $22.0 million and $25.0 million. Understanding these costs is crucial for assessing the company's operating efficiency and profitability margins.

Stocks: RXST